BBBryan Barcelona

Bryan Barcelona

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bryan Barcelona has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Drebrin forms a cortical hub that connects actin, microtubules, and clathrin for endocytic transport of β2 integrin

    by Pasquale Cervero, Sven Hey, Kathrin Weber, Bryan Barcelona, Robert Herzog, Stefan Linder

    Using primary human macrophages, we analyze the molecular machinery that enables direct contact of microtubule +tips with podosomes, and its connection to clathrin-based endocytosis. We show that the podosome cap protein drebrin, together with its +tip-localized binding partner EB3, regulates podosome-microtubule contact. Importantly, drebrin depletion leads to reduced endocytosis, particularly of β2 integrin at podosomes. This is based on drebrin's interaction with β2 integrin, and its direct binding of clathrin heavy chain via a canonical clathrin box and a novel box, which we identify also in other mammalian proteins. Our data enable a model of the molecular machinery that regulates direct contact between podosomes and microtubule +tips. Moreover, we provide evidence for spatial selectivity in endocytosis of β integrins, while also revealing a more general principle of endocytic trafficking regulation, through drebrin working as a multivalent, actin-based hub that links the clathrin system with microtubule-based transport.

  • Open Access

    KIF16B drives MT1-MMP recycling in macrophages and promotes co-invasion of cancer cells

    by Sven Hey, Christiane Wiesner, Bryan Barcelona, Stefan Linder

    The matrix metalloproteinase MT1-MMP is a central effector of cellular proteolysis. Accordingly, regulation of the surface-localized pool of MT1-MMP is crucial for cell migration and invasion. Here, we identify the superprocessive kinesin KIF16B as a major driver of fast recycling of MT1-MMP to the surface of primary human macrophages. KIF16B associates with MT1-MMP on Rab14-positive vesicles, and its depletion results in strongly reduced MT1-MMP surface levels, as shown by microscopical, biochemical, and cell-sorting approaches. As a consequence, KIF16B-depleted macrophages exhibit strongly reduced matrix degradation and invasion. We further identify the cargo-binding C-terminus of KIF16B as a critical element of MT1-MMP transport, as its overexpression uncouples MT1-MMP vesicles from the endogenous motor, thus leading to a reduction of surface-associated MT1-MMP and to reduced matrix degradation and invasion. Importantly, depletion of KIF16B in primary macrophages also reduces the co-invasion of cancer cells from tumor spheroids, pointing to the KIF16B-driven recycling pathway in macrophages as an important regulatory element of the tumor microenvironment.


  • Open Access

    Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells

    by Johannes Höfle, Timo Trenkner, Nadja Kleist, Vera Schwane, Sarah Vollmers, Bryan Barcelona, Annika Niehrs, Pia Fittje, Van Hung Huynh‐Tran, Jürgen Sauter, et al.

    NK cells utilize a large array of receptors to screen their surroundings for aberrant or virus‐infected cells. Given the vast diversity of receptors expressed on NK cells we seek to identify receptors involved in the recognition of HIV‐1‐infected cells. By combining an unbiased large‐scale screening approach with a functional assay, we identify TRAIL to be associated with NK cell degranulation against HIV‐1‐infected target cells. Further investigating the underlying mechanisms, we demonstrate that TRAIL is able to elicit multiple effector functions in human NK cells independent of receptor‐mediated induction of apoptosis. Direct engagement of TRAIL not only results in degranulation but also IFNγ production. Moreover, TRAIL‐mediated NK cell activation is not limited to its cognate death receptors but also decoy receptor I, adding a new perspective to the perceived regulatory role of decoy receptors in TRAIL‐mediated cytotoxicity. Based on these findings, we propose that TRAIL not only contributes to the anti‐HIV‐1 activity of NK cells but also possesses a multifunctional role beyond receptor‐mediated induction of apoptosis, acting as a regulator for the induction of different effector functions.